Relations of circulating GDF-15, soluble ST2, and troponin-I concentrations with vascular function in the community: The Framingham Heart Study

Atherosclerosis

Volumn 248, Issue , 2016, Pages 245-251

  Andersson, Charlotte ^a   Enserro, Danielle ^b   Sullivan, Lisa ^b   Wang, Thomas J ^a,c   Januzzi, James L ^d   Benjamin, Emelia J ^a,e,f   Vita, Joseph A ^e   Hamburg, Naomi M ^e   Larson, Martin G ^a   Mitchell, Gary F ^g   Vasan, Ramachandran S ^a,e,f  

^a FRAMINGHAM HEART STUDY   (United States)

^b BOSTON UNIVERSITY   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^g CARDIOVASCULAR ENGINEERING INC   (United States)

Author keywords

Biomarkers; Endothelial function; GDF 15; General population; ST2; Troponin I; Vascular stiffness

Indexed keywords

BIOLOGICAL MARKER; GROWTH DIFFERENTIATION FACTOR 15; SOLUBLE ST2 PROTEIN; TROPONIN I; UNCLASSIFIED DRUG; CREATININE; GDF15 PROTEIN, HUMAN; IL1RL1 PROTEIN, HUMAN; INTERLEUKIN 1 RECEPTOR LIKE 1 PROTEIN;

ADULT; ARTERIAL STIFFNESS; ARTICLE; AUGMENTATION INDEX; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR PARAMETERS; CAROTID ARTERY PULSE; FEMALE; FLOW RATE; FORWARD PRESSURE WAVE AMPLITUDE; HEART FAILURE; HEART STRESS; HUMAN; HYPEREMIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VASODILATATION; AGED; BLOOD; COHORT ANALYSIS; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; RISK FACTOR;

AGED; BIOMARKERS; CARDIOVASCULAR DISEASES; COHORT STUDIES; CREATININE; FEMALE; GROWTH DIFFERENTIATION FACTOR 15; HEART FAILURE; HUMANS; INTERLEUKIN-1 RECEPTOR-LIKE 1 PROTEIN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; RISK FACTORS; TROPONIN I; VASCULAR STIFFNESS;

EID: 84959876023     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2016.02.013     Document Type: Article

References (30)

1. Wang T.J., Wollert K.C., Larson M.G., Coglianese E., McCabe E.L., Cheng S., et al. Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham heart study. Circulation 2012, 126(13):1596-1604.
2. Xanthakis V., Larson M.G., Wollert K.C., Aragam J., Cheng S., Ho J., et al. Association of novel biomarkers of cardiovascular stress with left ventricular hypertrophy and dysfunction: implications for screening. J. Am. Heart Assoc. 2013, 2(6):e000399.
3. Ho J.E., Larson M.G., Ghorbani A., Cheng S., Vasan R.S., Wang T.J., et al. Soluble ST2 predicts elevated SBP in the community. J. Hypertens. 2013, 31(7):1431-1436. discussion 6.
4. Marti C.N., Gheorghiade M., Kalogeropoulos A.P., Georgiopoulou V.V., Quyyumi A.A., Butler J. Endothelial dysfunction, arterial stiffness, and heart failure. J. Am. Coll. Cardiol. 2012, 60(16):1455-1469.
5. Thanassoulis G., Lyass A., Benjamin E.J., Larson M.G., Vita J.A., Levy D., et al. Relations of exercise blood pressure response to cardiovascular risk factors and vascular function in the Framingham heart study. Circulation 2012, 125(23):2836-2843.
6. Kaess B.M., Rong J., Larson M.G., Hamburg N.M., Vita J.A., Levy D., et al. Aortic stiffness, blood pressure progression, and incident hypertension. JAMA 2012, 308(9):875-881.
7. Mitchell G.F., Hwang S.J., Vasan R.S., Larson M.G., Pencina M.J., Hamburg N.M., et al. Arterial stiffness and cardiovascular events: the Framingham heart study. Circulation 2010, 121(4):505-511.
8. Mitchell G.F., Parise H., Vita J.A., Larson M.G., Warner E., Keaney J.F., et al. Local shear stress and brachial artery flow-mediated dilation: the Framingham heart study. Hypertension 2004, 44(2):134-139.
9. Kathiresan S., Gona P., Larson M.G., Vita J.A., Mitchell G.F., Tofler G.H., et al. Cross-sectional relations of multiple biomarkers from distinct biological pathways to brachial artery endothelial function. Circulation 2006, 113(7):938-945.
10. Lieb W., Larson M.G., Benjamin E.J., Yin X., Tofler G.H., Selhub J., et al. Multimarker approach to evaluate correlates of vascular stiffness: the Framingham heart study. Circulation 2009, 119(1):37-43.
11. Rienstra M., Yin X., Larson M.G., Fontes J.D., Magnani J.W., McManus D.D., et al. Relation between soluble ST2, growth differentiation factor-15, and high-sensitivity troponin I and incident atrial fibrillation. Am. Heart J. 2014, 167(1). 109-15 e2.
12. Mitchell G.F., Parise H., Benjamin E.J., Larson M.G., Keyes M.J., Vita J.A., et al. Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham heart study. Hypertension 2004, 43(6):1239-1245.
13. Mitchell G.F., Izzo J.L., Lacourciere Y., Ouellet J.P., Neutel J., Qian C., et al. Omapatrilat reduces pulse pressure and proximal aortic stiffness in patients with systolic hypertension: results of the conduit hemodynamics of omapatrilat international research study. Circulation 2002, 105(25):2955-2961.
14. Mitchell G.F., Lacourciere Y., Ouellet J.P., Izzo J.L., Neutel J., Kerwin L.J., et al. Determinants of elevated pulse pressure in middle-aged and older subjects with uncomplicated systolic hypertension: the role of proximal aortic diameter and the aortic pressure-flow relationship. Circulation 2003, 108(13):1592-1598.
15. Kelly R., Fitchett D. Noninvasive determination of aortic input impedance and external left ventricular power output: a validation and repeatability study of a new technique. J. Am. Coll. Cardiol. 1992, 20(4):952-963.
16. Benjamin E.J., Larson M.G., Keyes M.J., Mitchell G.F., Vasan R.S., Keaney J.F., et al. Clinical correlates and heritability of flow-mediated dilation in the community: the Framingham heart study. Circulation 2004, 109(5):613-619.
17. Kempf T., Zarbock A., Widera C., Butz S., Stadtmann A., Rossaint J., et al. GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice. Nat. Med. 2011, 17(5):581-588.
18. Nickel N., Jonigk D., Kempf T., Bockmeyer C.L., Maegel L., Rische J., et al. GDF-15 is abundantly expressed in plexiform lesions in patients with pulmonary arterial hypertension and affects proliferation and apoptosis of pulmonary endothelial cells. Respir. Res. 2011, 12:62.
19. Schlittenhardt D., Schober A., Strelau J., Bonaterra G.A., Schmiedt W., Unsicker K., et al. Involvement of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions. Cell Tissue Res. 2004, 318(2):325-333.
20. Ago T., Sadoshima J. GDF15, a cardioprotective TGF-beta superfamily protein. Circ. Res. 2006, 98(3):294-297.
21. Lind L., Wallentin L., Kempf T., Tapken H., Quint A., Lindahl B., et al. Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the prospective investigation of the vasculature in uppsala seniors (PIVUS) study. Eur. Heart J. 2009, 30(19):2346-2353.
22. van Popele N.M., Grobbee D.E., Bots M.L., Asmar R., Topouchian J., Reneman R.S., et al. Association between arterial stiffness and atherosclerosis: the Rotterdam study. Stroke 2001, 32(2):454-460.
23. Rohatgi A., Patel P., Das S.R., Ayers C.R., Khera A., Martinez-Rumayor A., et al. Association of growth differentiation factor-15 with coronary atherosclerosis and mortality in a young, multiethnic population: observations from the Dallas heart study. Clin. Chem. 2012, 58(1):172-182.
24. Sanada S., Hakuno D., Higgins L.J., Schreiter E.R., McKenzie A.N., Lee R.T. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J. Clin. Investig. 2007, 117(6):1538-1549.
25. Kakkar R., Lee R.T. The IL-33/ST2 pathway: therapeutic target and novel biomarker. Nat. Rev. Drug Discov. 2008, 7(10):827-840.
26. Choi Y.S., Choi H.J., Min J.K., Pyun B.J., Maeng Y.S., Park H., et al. Interleukin-33 induces angiogenesis and vascular permeability through ST2/TRAF6-mediated endothelial nitric oxide production. Blood 2009, 114(14):3117-3126.
27. de Lemos J.A., Drazner M.H., Omland T., Ayers C.R., Khera A., Rohatgi A., et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA J. Am. Med. Assoc. 2010, 304(22):2503-2512.
28. deFilippi C.R., de Lemos J.A., Christenson R.H., Gottdiener J.S., Kop W.J., Zhan M., et al. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA 2010, 304(22):2494-2502.
29. Bai Y., Ye P., Luo L., Xiao W., Xu R., Wu H., et al. Arterial stiffness is associated with minimally elevated high-sensitivity cardiac, troponin T levels in a community-dwelling population. Atherosclerosis 2011, 218(2):493-498.
30. Yiu K.H., Zhao C.T., Chen Y., Siu C.W., Chan Y.H., Lau K.K., et al. Association of subclinical myocardial injury with arterial stiffness in patients with type 2 diabetes mellitus. Cardiovasc. Diabetol. 2013, 12:94.